Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Recent blog posts
Latest Hotspot
8 min read
NCT07547332 Albumin-Bound Paclitaxel Recurrent Lung Small Cell Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07547332 clinical trial report covering Albumin-Bound Paclitaxel, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07547930 Tofacitinib Citrate Glucocorticoid Receptor Deficiency Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07547930 clinical trial report covering Tofacitinib Citrate, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07548918 Minoxidil Vitiligo Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07548918 clinical trial report covering Minoxidil, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07548710 Sonrotoclax Adult Acute Myeloblastic Leukemia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07548710 clinical trial report covering Sonrotoclax, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07547592 Gemfibrozil Soft Tissue Sarcoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07547592 clinical trial report covering Gemfibrozil, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07548450 Mosunetuzumab Waldenstrom's macroglobulinaemia refractory Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07548450 clinical trial report covering Mosunetuzumab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07548047 Dextrose Postoperative air leak Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07548047 clinical trial report covering Dextrose, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07547436 SAR-445399 Non-cystic fibrosis bronchiectasis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07547436 clinical trial report covering SAR-445399, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07546812 Denikitug Adenocarcinoma of Esophagus Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07546812 clinical trial report covering Denikitug, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07547995 Genakumab Non-infectious posterior uveitis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07547995 clinical trial report covering Genakumab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07549646 Trametinib dimethyl sulfoxide Vascular Malformations Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07549646 clinical trial report covering Trametinib dimethyl sulfoxide, Phase 2, endpoints, sponsor, geography, readout timing and development white spac
Read →
Latest Hotspot
8 min read
NCT07549906 Iparomlimab/Tuvonralimab pMMR/MSS/MSI-L Colon Cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07549906 clinical trial report covering Iparomlimab/Tuvonralimab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Read →
<
1
<<
161
162
163
164
165
>>
920
>